Baillie Gifford & Co’s NEVRO CORP. NVRO Stock Holding History

Baillie Gifford & Co’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-154	Closed	-$6.1K	–	481
2022 Q4	$6.1K	Hold	154	–	–	﹤0.01%	437
2022 Q3	$7K	Hold	154	–	–	﹤0.01%	432
2022 Q2	$7K	Hold	154	–	–	﹤0.01%	444
2022 Q1	$11K	Hold	154	–	–	﹤0.01%	431
2021 Q4	$12K	Hold	154	–	–	﹤0.01%	432
2021 Q3	$18K	Hold	154	–	–	﹤0.01%	387
2021 Q2	$26K	Hold	154	–	–	﹤0.01%	333
2021 Q1	$21K	Buy	154 +6	+4%	+$979	﹤0.01%	331
2020 Q4	$26K	Buy	+148	New	+$24K	﹤0.01%	305

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co's NVRO Position: Q1 2023 in Review

Baillie Gifford & Co sold out of NEVRO CORP. (NVRO) in Q1 2023, closing a stake of 154 shares — an estimated $6.1K sold.

Baillie Gifford & Co first reported a position in NVRO in Q4 2020 and held it in 9 quarters. The position peaked at $26K in Q2 2021. 158 funds tracked by Wall St. Rank hold NVRO as of Q1 2023.

Baillie Gifford & Co reported no remaining NEVRO CORP. position as of Q1 2023 after selling out during the quarter.
Baillie Gifford & Co sold 154 NEVRO CORP. shares in Q1 2023, an estimated $6.1K.
Baillie Gifford & Co first reported a position in NEVRO CORP. in Q4 2020 and held it in 9 quarters.
Baillie Gifford & Co's NEVRO CORP. position peaked at $26K in Q2 2021.
158 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2023.

Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.